July 11th- Prof. Thomas Cluzeau- Overall Survival and Duration of Transfusion Independence for First-Line ESA-Naive Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept vs Epoetin Alfa in the COMMANDS Trial

July 8th- Dr. Ofir Wolach- Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study

July 3rd- Prof. Ola Landrgen- Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Mohamad Mohty- Best of myélome à l'EHA 2025

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Arthur Bobin- ISASOCUT

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Jean-Marc Schiano- Le myélome de haut risque

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Dr. Levy- Les recommandation EHA-EMN

June 17th- Prof. Dimitrios Mougiakakos- CAR T cells in autoimmunity: game changer or stepping stone?

June 15th- IACH Radio: On Air from EHA 2025- Prof. Mohamad Mohty- Myeloma summary from #EHA2025

June 15th- IACH Radio: On Air from EHA 2025- Bipin Savani- Advances in myeloid malignancies at #EHA2025